The 20 Best Retinoblastoma Doctors in The United States

Carol Shields is an Oncologist and an Ophthalmologist practicing medicine in Philadelphia, Pennsylvania. Dr. Shields is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Uveal Melanoma, Vitrectomy, and Iridectomy. Dr. Shields is board certified in Ophthalmology. Dr. Shields is currently accepting new patients.

Jesse Berry is an Ophthalmologist practicing medicine in Los Angeles, California. Dr. Berry is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Vitrectomy, and Cataract Removal. Dr. Berry is board certified in Ophthalmology. Dr. Berry is currently accepting new patients.

Hans Grossniklaus is an Ophthalmologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 46 years. Dr. Grossniklaus is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Uveal Melanoma, Metastatic Uveal Melanoma, Vitrectomy, and Corneal Transplant. Dr. Grossniklaus is board certified in American Board Of Pathology, 1987.

David Abramson is an Oncologist practicing medicine in New York, New York. Dr. Abramson is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Hereditary Retinoblastoma, Melanoma of the Eye, Vitrectomy, and Leg or Foot Amputation. Dr. Abramson is currently accepting new patients.

Jasmine Francis is an Oncologist practicing medicine in New York, New York. Dr. Francis is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Vitrectomy, and Liver Embolization. Dr. Francis is currently accepting new patients.

Brian Marr, MD heads the Ophthalmic Oncology Service at the Harkness Eye Institute. He has comprehensive experience in the diagnosis, treatment, and management of ocular tumors including intraocular tumor resection, laser, radiation, and chemotherapy procedures. He has helped devise thousands of complex treatments for tumors of the eye, eyelid, orbit, and conjunctiva for his adult, children, and infant patients. Currently, Dr. Marr is a collaborator on a Columbia University clinical trial for a first-of-its-kind, new class of drug treatment for uveal melanoma.Dr. Marr is a board-certified ophthalmologist whose work has centered around ophthalmic oncology since 2000. One of the very few ocular oncologists trained in all aspects of eye cancer, Dr. Marr's clinical experience in treating these diseases is among the most extensive in the United States. His interest and experience in ophthalmic oncology began during an eight-year tenure in the Ocular Oncology Service at the Wills Eye Hospital in Philadelphia. There, he gained extensive experience treating intraocular tumors, and tumors of the eyelid, orbit, and conjunctiva in children and adults. It was there that Dr. Marr developed and improved many surgical procedures used to cure cancers of the eye, successfully treated thousands of patients, and helped their families though their battle with eye cancer. Next, Dr. Marr moved on to Memorial Sloan Kettering Cancer Center, where he remain for nine years, starting in 2008.Dr. Marr has some of the greatest experience with intra-arterial chemotherapy for treating retinoblastoma in the country, if not the world, as well as all other forms of retinoblastoma treatment. He has been a key member of many multidisciplinary surgical teams, treating advanced skull base tumors and complex facial skin lesions. He has developed a strong belief and treatment philosophy that the best research be used to help his patients, rather than his best patients be used to help his research. The field of ophthalmic oncology encompasses many rare conditions and his experience helps his patients get the best care and results as quickly as possible. Dr. Marr lectures and consults across the US and abroad, and has authored numerous research articles in the field of ocular oncology. He is the principal investigator in a first-in-class drug study for treating primary uveal melanoma, in an international, multi-center trial. He also volunteers his medical expertise in underserviced parts of the world, such as Nigeria and Indonesia, and has helped train physicians in more than 20 countries. Dr. Marr’s efforts as a contributor to ongoing education in ocular oncology have been recognized by the American Academy of Ophthalmology, where he now serves as chief editor of the Academy’s Oncology and Pathology’s One network. Dr. Marr is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, and Vitrectomy. Dr. Marr is board certified in Ophthalmology. Dr. Marr is currently accepting new patients.

Scott E. Brodie, MD, Ph.D., is a Professor of Clinical Ophthalmology and Attending Ophthalmologist in the Department of Ophthalmology. He is an internationally known clinician-scientist, and a leader in the use of electrophysiologic techniques for diagnosing of visual impairments in children and adults.Dr. Brodie is a graduate of the combined MD-PhD program at Weill-Cornell Medical College and The Rockefeller University in New York. He completed his PhD in retinal physiology in the laboratory of Nobel Laureate H. K. Hartline, under the supervision of Dr. Floyd Ratliff and Prof. Bruce Knight. He completed a medical internship and residency training in ophthalmology at The New York Hospital, and subsequently received fellowship training in medical retinal disorders and clinical electrophysiology of vision at New York University and Bellevue Hospital under the supervision of Dr. Ronald Carr, with support as a John Kluge Fellow of the Retinitis Pigmentosa Foundation.He is a fellow of the American Academy of Ophthalmology, and a fellow of the Association for Research in Vision and Ophthalmology. He is a member of the International Society for Clinical Electrophysiology of Vision, the International Society for Genetic Eye Disease, and the Ophthalmic Genetics Study Club. Dr. Brodie has been honored with the Senior Achievement Award of the American Academy of Ophthalmology, as well as the Academy's Secretariat Award for Education.Dr. Brodie’s research centers on improving methodologies for electrophysiologic testing, and descriptions of novel findings in patients with inherited and metabolic retinal disorders. He has been a key member of the teams which have introduced important new therapies, including enzyme-replacement therapy for Fabry disease, and intra-arterial chemotherapy for retinoblastoma, which has increased the rate of salvage of diseased eyes in the most severely affected patients from 20% to over 90%.Dr. Brodie has published extensively on electrophysiology and retinal disorders. He has a particular interest in clinical optics, and has served as Chair of the Editorial committee for the American Academy of Ophthalmology’s Basic and Clinical Science Course on Clinical Optics for the past ten years. In his spare time, he enjoys reading mathematics, and playing the oboe in local orchestras and chamber groups. Dr. Brodie is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Retinitis Pigmentosa, Cone-Rod Dystrophy, Retinopathy Pigmentary Mental Retardation, and Vitrectomy. Dr. Brodie is currently accepting new patients.

Hakan Demirci is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Demirci is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Retinoblastoma, Metastatic Uveal Melanoma, Uveal Melanoma, and Vitrectomy.

Rachel Brennan is a Hematologist and an Oncologist practicing medicine in Kalispell, Montana. Dr. Brennan is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Retinoblastoma, Epidural Lipomatosis, Familial Multiple Lipomatosis, Neuroblastoma, and Nephrectomy.

Ira Dunkel is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Dunkel is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Diffuse Midline Glioma H3 K27M-Mutant, Brain Stem Cancer, and Glioma. Dr. Dunkel is currently accepting new patients.

Rima Jubran is a Hematologist and an Oncologist practicing medicine in Los Angeles, California. Dr. Jubran is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Retinoblastoma, Langerhans Cell Histiocytosis, Hereditary Retinoblastoma, and Reticulohistiocytoma.

Aparna Ramasubramanian is an Ophthalmologist practicing medicine in Phoenix, Arizona. Dr. Ramasubramanian is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Retinoblastoma, Strabismus, Brown Syndrome, and Hereditary Retinoblastoma. Dr. Ramasubramanian is board certified in Ophthalmology.

Andrew Stacey is an Ophthalmologist practicing medicine in Seattle, Washington. Dr. Stacey is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Choroid Plexus Carcinoma, Tissue Biopsy, and Vitrectomy.

Y Gobin is a Radiologist practicing medicine in New York, New York. Dr. Gobin is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Brain Aneurysm, Hereditary Retinoblastoma, Arteriovenous Malformation, and Thrombectomy.

Carlos Rodriguez is a Hematologist and an Oncologist practicing medicine in Memphis, Tennessee. Dr. Rodriguez is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Germ Cell Tumor, Retinoblastoma, Langerhans Cell Histiocytosis, Hepatectomy, and Tissue Biopsy.

Sara Lally is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Lally is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Melanoma of the Eye, Retinoblastoma, Metastatic Uveal Melanoma, and Hereditary Retinoblastoma.

Anthony Daniels is an Ophthalmologist practicing medicine in New Haven, Connecticut. Dr. Daniels is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Uveal Melanoma, and Metastatic Uveal Melanoma.

Ibrahim Qaddoumi is a Hematologist and an Oncologist practicing medicine in Memphis, Tennessee. Dr. Qaddoumi is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Glioma, Ganglioglioma, and Optic Glioma.

Lauren Dalvin is an Ophthalmologist practicing medicine in Virginia Beach, Virginia. Dr. Dalvin is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Melanoma of the Eye, Uveal Melanoma, Retinoblastoma, Coats Disease, and Vitrectomy.

Dan Gombos is an Ophthalmologist practicing medicine in Cary, North Carolina. Dr. Gombos is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Metastatic Uveal Melanoma, Retinoblastoma, and Uveal Melanoma.